A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes
Status:
TERMINATED
Trial end date:
2025-07-29
Target enrollment:
Participant gender:
Summary
The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to evaluate the effects of treatment with LY3549492 compared to placebo in adult participants with obesity or who are overweight with type 2 diabetes.
Participation in the study will last about 11 months.